Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Comprehensive definition of human immunodominant CD8 antigens in tuberculosis.

NPJ vaccines

Lewinsohn DA, Swarbrick GM, Park B, Cansler ME, Null MD, Toren KG, Baseke J, Zalwango S, Mayanja-Kizza H, Malone LL, Nyendak M, Wu G, Guinn K, McWeeney S, Mori T, Chervenak KA, Sherman DR, Boom WH, Lewinsohn DM.
PMID: 28775896
NPJ Vaccines. 2017;2. doi: 10.1038/s41541-017-0008-6. Epub 2017 Apr 03.

Despite widespread use of the Bacillus Calmette-Guerin vaccine, tuberculosis, caused by infection with

Cite
Lewinsohn DA, Swarbrick GM, Park B, et al. Comprehensive definition of human immunodominant CD8 antigens in tuberculosis. NPJ Vaccines. 2017;2doi: 10.1038/s41541-017-0008-6.
Lewinsohn, D. A., Swarbrick, G. M., Park, B., Cansler, M. E., Null, M. D., Toren, K. G., Baseke, J., Zalwango, S., Mayanja-Kizza, H., Malone, L. L., Nyendak, M., Wu, G., Guinn, K., McWeeney, S., Mori, T., Chervenak, K. A., Sherman, D. R., Boom, W. H., & Lewinsohn, D. M. (2017). Comprehensive definition of human immunodominant CD8 antigens in tuberculosis. NPJ vaccines, 2. https://doi.org/10.1038/s41541-017-0008-6
Lewinsohn, Deborah A, et al. "Comprehensive definition of human immunodominant CD8 antigens in tuberculosis." NPJ vaccines vol. 2 (2017). doi: https://doi.org/10.1038/s41541-017-0008-6
Lewinsohn DA, Swarbrick GM, Park B, Cansler ME, Null MD, Toren KG, Baseke J, Zalwango S, Mayanja-Kizza H, Malone LL, Nyendak M, Wu G, Guinn K, McWeeney S, Mori T, Chervenak KA, Sherman DR, Boom WH, Lewinsohn DM. Comprehensive definition of human immunodominant CD8 antigens in tuberculosis. NPJ Vaccines. 2017;2. doi: 10.1038/s41541-017-0008-6. Epub 2017 Apr 03. PMID: 28775896; PMCID: PMC5538316.
Copy Download .nbib Format: NLM
Cellular and molecular analysis of tumor-infiltrating T-lymphocytes from human breast-cancer at clonal level.

Oncology reports

Chin Y, Janssens J, Bleus J, Zhang J, Raus J.
PMID: 21607407
Oncol Rep. 1994 May;1(3):577-83. doi: 10.3892/or.1.3.577.

51 T cell lines/clones were established from tumor-infiltrating lymphocytes of nine breast tumors by limiting dilution. All the lines/clones were exclusively CD3+ and expressed either CD4 (57%) or CD8 (26%) phenotype. In addition, 17% of the lines/clones displayed a...

Cite
Chin Y, Janssens J, Bleus J, et al. Cellular and molecular analysis of tumor-infiltrating T-lymphocytes from human breast-cancer at clonal level. Oncol Rep. 1994;1(3):577-83doi: 10.3892/or.1.3.577.
Chin, Y., Janssens, J., Bleus, J., Zhang, J., & Raus, J. (1994). Cellular and molecular analysis of tumor-infiltrating T-lymphocytes from human breast-cancer at clonal level. Oncology reports, 1(3), 577-83. https://doi.org/10.3892/or.1.3.577
Chin, Y, et al. "Cellular and molecular analysis of tumor-infiltrating T-lymphocytes from human breast-cancer at clonal level." Oncology reports vol. 1,3 (1994): 577-83. doi: https://doi.org/10.3892/or.1.3.577
Chin Y, Janssens J, Bleus J, Zhang J, Raus J. Cellular and molecular analysis of tumor-infiltrating T-lymphocytes from human breast-cancer at clonal level. Oncol Rep. 1994 May;1(3):577-83. doi: 10.3892/or.1.3.577. PMID: 21607407.
Copy Download .nbib Format: NLM
Immunologic Findings in B-Chronic Lymphocytic Leukemia Patients Treated with α2b-Interferon.

Leukemia & lymphoma

Panaytotidis PG, Boussiotis VA, Pangallis GA.
PMID: 27463991
Leuk Lymphoma. 1990;1(3):235-40. doi: 10.3109/10428199009042485.

The immune function of seventeen previously untreated stage A, B-chronic lymphocytic leukemia (B-CLL) patients receiving α2b-interferon (α2b-IFN) was studied before therapy and three months later. In eleven patients a decrease of absolute blood lymphocyte numbers was observed, due to...

Cite
Panaytotidis PG, Boussiotis VA, Pangallis GA. Immunologic Findings in B-Chronic Lymphocytic Leukemia Patients Treated with α2b-Interferon. Leuk Lymphoma. 1990;1(3):235-40doi: 10.3109/10428199009042485.
Panaytotidis, P. G., Boussiotis, V. A., & Pangallis, G. A. (1990). Immunologic Findings in B-Chronic Lymphocytic Leukemia Patients Treated with α2b-Interferon. Leukemia & lymphoma, 1(3), 235-40. https://doi.org/10.3109/10428199009042485
Panaytotidis, P G, et al. "Immunologic Findings in B-Chronic Lymphocytic Leukemia Patients Treated with α2b-Interferon." Leukemia & lymphoma vol. 1,3 (1990): 235-40. doi: https://doi.org/10.3109/10428199009042485
Panaytotidis PG, Boussiotis VA, Pangallis GA. Immunologic Findings in B-Chronic Lymphocytic Leukemia Patients Treated with α2b-Interferon. Leuk Lymphoma. 1990;1(3):235-40. doi: 10.3109/10428199009042485. PMID: 27463991.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries